Cargando…

Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience

INTRODUCTION: Rituximab (RTX) is considered a potential therapeutic option for relapsing-remitting (RRMS) and progressive forms (PMS) of multiple sclerosis (MS). The main objective of this work was to investigate the effectiveness and safety of rituximab in MS. PATIENTS AND METHODS: Observational mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gascón-Giménez, Francisco, Alcalá, Carmen, Ramió-Torrentà, Lluís, Montero, Paloma, Matías-Guiu, Jorge, Gómez-Estevez, Irene, Oreja-Guevara, Celia, Gil-Perotín, Sara, Blanco, Yolanda, Carcelén, María, Quintanilla-Bordás, Carlos, Costa, Lucienne, Villar, Luisa Maria, Martínez-Rodriguez, Jose Enrique, Domínguez, José Andrés, Calles, Carmen, González, Inés, Sotoca, Javier, Oterino, Agustin, Lucas-Jimenez, Celia, Pérez-Miralles, Francisco, Casanova, Bonaventura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027934/ https://www.ncbi.nlm.nih.gov/pubmed/36959824 http://dx.doi.org/10.3389/fneur.2023.1060696

Ejemplares similares

Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis
por: Alcalá Vicente, Carmen, et al.
Publicado: (2022)

Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain
por: Landete, Lamberto, et al.
Publicado: (2021)

Cognitive Dysfunctions and Assessments in Multiple Sclerosis
por: Oreja-Guevara, Celia, et al.
Publicado: (2019)

Escalation vs. Early Intense Therapy in Multiple Sclerosis
por: Casanova, Bonaventura, et al.
Publicado: (2022)

Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies
por: Coret, Francisco, et al.
Publicado: (2018)

Perception of stigma in patients with primary progressive multiple sclerosis
por: Pérez-Miralles, Francisco, et al.
Publicado: (2019)

Integrated Management of Multiple Sclerosis Spasticity and Associated Symptoms Using the Spasticity-Plus Syndrome Concept: Results of a Structured Specialists' Discussion Using the Workmat(®) Methodology
por: Fernandez, Oscar, et al.
Publicado: (2021)

Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis
por: Gil-Perotin, Sara, et al.
Publicado: (2019)

Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis
por: Pérez‐Miralles, Francisco Carlos, et al.
Publicado: (2021)

Consensus on early detection of disease progression in patients with multiple sclerosis
por: Meca-Lallana, José E., et al.
Publicado: (2022)

High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis
por: Castillo-Villalba, Jéssica, et al.
Publicado: (2022)

Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series
por: Quintanilla-Bordás, Carlos, et al.
Publicado: (2022)

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
por: Casanova, Bonaventura, et al.
Publicado: (2017)

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
por: Ramo-Tello, Cristina, et al.
Publicado: (2021)

Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report
por: Gil-Perotin, Sara, et al.
Publicado: (2018)

XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)
por: Fernández, Óscar, et al.
Publicado: (2023)

XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)
por: Fernández, Óscar, et al.
Publicado: (2023)

Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial
por: Villoslada, Pablo, et al.
Publicado: (2015)

Potential Role of CHI3L1+ Astrocytes in Progression in MS
por: Cubas-Núñez, Laura, et al.
Publicado: (2021)

CSF chitinase 3-like-1 association with disability of primary progressive MS
por: Pérez-Miralles, Francisco, et al.
Publicado: (2020)

The Broad Concept of “Spasticity-Plus Syndrome” in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis Symptoms
por: Fernández, Óscar, et al.
Publicado: (2020)

Clinical and radiological features of cerebral amyloid angiopathy-related inflammation
por: Bravo, Gary Álvarez, et al.
Publicado: (2021)

Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus
por: Sepúlveda, Maria, et al.
Publicado: (2016)

Recent advances in early stage lung cancer
por: Luna, Javier, et al.
Publicado: (2021)

Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives
por: Bravo, Gary Álvarez, et al.
Publicado: (2022)

Functional Components of Cognitive Impairment in Multiple Sclerosis: A Cross-Sectional Investigation
por: Matias-Guiu, Jordi A., et al.
Publicado: (2017)

Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging
por: Matías-Guiu, Jordi A., et al.
Publicado: (2016)

Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype
por: Cantó, Laura Navarro, et al.
Publicado: (2019)

Clinical heterogeneity in patients with myoclonus associated to COVID-19
por: Álvarez Bravo, Gary, et al.
Publicado: (2022)

Disease-related knowledge measurement instruments of people affected by multiple sclerosis: protocol for a systematic psychometric review
por: Gonzalez-del-Rio, Marina, et al.
Publicado: (2021)

Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection
por: Alvarez Bravo, G., et al.
Publicado: (2020)

Encefalitis anti-NMDA-R secundaria a infección por SARS-CoV-2
por: Álvarez Bravo, G., et al.
Publicado: (2020)

Paraneoplastic Limbic Encephalitis in a Male with Squamous Cell Carcinoma of the Lung
por: Sauri, Tamara, et al.
Publicado: (2015)

Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study
por: Matías-Guiu, Jordi A., et al.
Publicado: (2015)

miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis
por: Muñoz-San Martín, María, et al.
Publicado: (2022)

Description of a CSF-Enriched miRNA Panel for the Study of Neurological Diseases
por: Muñoz-San Martín, María, et al.
Publicado: (2021)

Familial multiple sclerosis and association with other autoimmune diseases
por: Pytel, Vanesa, et al.
Publicado: (2017)

Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
por: Meca-Lallana, José E., et al.
Publicado: (2023)

Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions
por: Muñoz-San Martín, María, et al.
Publicado: (2019)

Evaluating the effect of multiple sclerosis lesions on automatic brain structure segmentation
por: González-Villà, Sandra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fl21e435mfjob831fiakqr5irf